FDA Issues New Guidance On Discontinuance Or Interruption In Manufacturing Of Finished Products Or APIs

In April 2023, the FDA issued an updated guidance superseding and replacing the previous 2020 document about managing drug shortages and explaining...

Related Keywords

Peterh Calcott , ,Calcott Consulting ,National Drug Code ,Field Alerts ,Biological Product Deviation Reports ,Permanent Discontinuance ,